The role of YAP/TAZ in chroidal vascular structure and choroidal neovascularization
Project/Area Number |
18K16926
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 56060:Ophthalmology-related
|
Research Institution | Kobe University |
Principal Investigator |
|
Project Period (FY) |
2018-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2018: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Keywords | YAP/TAZ / pYAP / 脈絡膜新生血管 / 脈絡膜 / 脈絡膜血管内皮細胞 / ベルテポルフィン / YAP / 実験的脈絡膜血管新生 / 脈絡膜血管形態 / YAPTAZ / 血管新生 / ポリープ状脈絡膜血管症 |
Outline of Final Research Achievements |
This study aims to clarify the role of the Hippo pathway effector YAP / TAZ in choroidal angiogenesis (CNV). In an experiment to see the effect of the YAP inhibitor, verteporfin (VP), using a laser-induced CNV model, the CNV volume was significantly smaller in VP treatment than in control. Thus, it was suggested that VP might suppress CNV progression by YAP inhibitory action. We also investigated the effect of VP on YAP in choroidal blood vessels using human choroidal vascular endothelial cells and found that as the VP concentration increased, the intranuclear transition of pYAP was suppressed. The above suggests that YAP may play an important role in choroidal blood vessels.
|
Academic Significance and Societal Importance of the Research Achievements |
近年、加齢黄斑変性(AMD)の一亜型であるポリープ状脈絡膜血管症(PCV)の治療において、YAP阻害作用を持つベルテポルフィンを用いた光線力学療法の有効性が臨床的に注目されている。本研究では、AMDの病態の首座である脈絡膜血管においてYAPが重要な役割を担っている可能性が示唆された。本研究の結果が、今後、YAPを介するHippo経路をターゲットにしたAMD及びPCV治療の臨床応用につながる可能性が期待される。
|
Report
(5 results)
Research Products
(29 results)
-
-
-
-
-
-
-
[Journal Article] Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas2021
Author(s)
Kim KW, Kusuhara S, Katsuyama-Yoshikawa A, Nobuyoshi S, Kitamura M, Mori S, Sotani N, Ueda K, Matsumiya W, Miki A, Kurimoto T, Imai H, Nakamura M.
-
Journal Title
Antioxidants (Basel)
Volume: 15
Issue: 3
Pages: 455-455
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Presentation] Association of oral montelukast with reduced odds of developing neovascular age-related macular degeneration2021
Author(s)
Irmak Karaca, Wataru Matsumiya, Amir Akhavanrezayat, Gunay Uludag, Cigdem Yasar, Hashem Ghoraba, Azadeh Mobasserian, Jonathan Regenold, Brandon Huy Pham, Rubbia Afridi, Muhammad Sohail Halim, Diana V. Do, Yasir J. Sepah, Quan Dong Nguyen,
Organizer
ARVO2021
Related Report
-
-
[Presentation] Correlation between photoreceptor density in adaptive optics imaging with retinal structure and sensitivity in autoimmune retinopathy2021
Author(s)
Wataru Matsumiya, Amir Akhavanrezayat, Gunay Uludag, Cigdem Yasar, Hashem Ghoraba, Azadeh Mobasserian, Irmak Karaca, Brandon Pham, Jaclyn Joyce Hwang, Rubbia Afridi, Muhammad Sohail Halim, Diana V. Do, Yasir J. Sepah, Quan Dong Nguyen
Organizer
ARVO2021
Related Report
-
[Presentation] Photoreceptor Density in Adaptive Optics Imaging Is Correlated With Retinal Structure and Sensitivity in Autoimmune Retinopathy2021
Author(s)
Wataru Matsumiya, Amir Akhavanrezayat, Gunay Uludag, Cigdem Yasar, Hashem Ghoraba, Azadeh Mobasserian, Irmak Karaca, Jonathan Regenold, Brandon Pham, Muhammad Sohail Halim, Diana V. Do, Yasir J. Sepah, Quan Dong Nguyen
Organizer
American Academy of Ophthalmology(AAO)2021
Related Report
-
-
-
-
-
-
-
-
-
[Presentation] Wataru Matsumiya, Mayuka Hayashida, Ryuto Nishisyo, Akira Tetsumoto, Atsuko Katsuyama, Akiko Miki, Hisanori Imai, Sentaro Kusuhara, Makoto Nakamura2019
Author(s)
Wataru Matsumiya, Mayuka Hayashida, Ryuto Nishisyo, Akira Tetsumoto, Atsuko Katsuyama, Akiko Miki, Hisanori Imai, Sentaro Kusuhara, Makoto Nakamura
Organizer
GOIW (Global Ocular Inflammation Workshops) 2019
Related Report
-
-
-
-
-